Relevant bibliographies by topics / ME163

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'ME163'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'ME163.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "ME163"

1

Berardelli, A. "ME13 Pathophysiology of dystonia." Clinical Neurophysiology 119 (May 2008): S4. http://dx.doi.org/10.1016/s1388-2457(08)60020-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

H-Kittikun, Aran, Poonsuk Prasertsan, Wolfgang Zimmermann, Phisit Seesuriyachan, and Thanongsak Chaiyaso. "Sugar Ester Synthesis by Thermostable Lipase from Streptomyces thermocarboxydus ME168." Applied Biochemistry and Biotechnology 166, no. 8 (March 21, 2012): 1969–82. http://dx.doi.org/10.1007/s12010-012-9624-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Neilson, Lynn M., Jianquong Zhu, Jianwu Xie, M. Grazia Malabarba, Kazuhito Sakamoto, Kay-Uwe Wagner, Robert A. Kirken, and Hallgeir Rui. "Coactivation of Janus Tyrosine Kinase (Jak)1 Positively Modulates Prolactin-Jak2 Signaling in Breast Cancer: Recruitment of ERK and Signal Transducer and Activator of Transcription (Stat)3 and Enhancement of Akt and Stat5a/b Pathways." Molecular Endocrinology 21, no. 9 (September 1, 2007): 2218–32. http://dx.doi.org/10.1210/me.2007-0173.

Full text
Abstract:
Abstract Prolactin (PRL) receptors (PRLRs) have been considered selective activators of Janus tyrosine kinase (Jak)2 but not Jak1, Jak3, or Tyk2. We now report marked PRL-induced tyrosine phosphorylation of Jak1, in addition to Jak2, in a series of human breast cancer cell lines, including T47D, MCF7, and SKBR3. In contrast, PRL did not activate Jak1 in immortalized, noncancerous breast epithelial lines HC11, MCF10A, ME16C, and HBL-100, or in CWR22Rv1 prostate cancer cells or MDA-MB-231 breast cancer cells. However, introduction of exogenous PRLR into MCF10A, ME16C, or MDA-MB-231 cells reconstituted both PRL-Jak1 and PRL-Jak2 signals. In vitro kinase assays verified that PRL stimulated enzymatic activity of Jak1 in T47D cells, and PRL activated Jak1 and Jak2 with indistinguishable time and dose kinetics. Relative Jak2 deficiency did not cause PRLR activation of Jak1, because overexpression of Jak2 did not interfere with PRL activation of Jak1. Instead, PRL activated Jak1 through a Jak2-dependent mechanism, based on disruption of PRL activation of Jak1 after Jak2 suppression by 1) lentiviral delivery of Jak2 short hairpin RNA, 2) adenoviral delivery of dominant-negative Jak2, and 3) AG490 pharmacological inhibition. Finally, suppression of Jak1 by lentiviral delivery of Jak1 short hairpin RNA blocked PRL activation of ERK and signal transducer and activator of transcription (Stat)3 and suppressed PRL activation of Jak2, Stat5a, Stat5b, and Akt, as well as tyrosine phosphorylation of PRLR. The data suggest that PRL activation of Jak1 represents a novel, Jak2-dependent mechanism that may serve as a regulatory switch leading to PRL activation of ERK and Stat3 pathways, while also serving to enhance PRL-induced Stat5a/b and Akt signaling.
APA, Harvard, Vancouver, ISO, and other styles
4

Coulon, Frédéric, Panagiota-Myrsini Chronopoulou, Anne Fahy, Sandrine Païssé, Marisol Goñi-Urriza, Louis Peperzak, Laura Acuña Alvarez, et al. "Central Role of Dynamic Tidal Biofilms Dominated by Aerobic Hydrocarbonoclastic Bacteria and Diatoms in the Biodegradation of Hydrocarbons in Coastal Mudflats." Applied and Environmental Microbiology 78, no. 10 (March 9, 2012): 3638–48. http://dx.doi.org/10.1128/aem.00072-12.

Full text
Abstract:
ABSTRACTMudflats and salt marshes are habitats at the interface of aquatic and terrestrial systems that provide valuable services to ecosystems. Therefore, it is important to determine how catastrophic incidents, such as oil spills, influence the microbial communities in sediment that are pivotal to the function of the ecosystem and to identify the oil-degrading microbes that mitigate damage to the ecosystem. In this study, an oil spill was simulated by use of a tidal chamber containing intact diatom-dominated sediment cores from a temperate mudflat. Changes in the composition of bacteria and diatoms from both the sediment and tidal biofilms that had detached from the sediment surface were monitored as a function of hydrocarbon removal. The hydrocarbon concentration in the upper 1.5 cm of sediments decreased by 78% over 21 days, with at least 60% being attributed to biodegradation. Most phylotypes were minimally perturbed by the addition of oil, but at day 21, there was a 10-fold increase in the amount of cyanobacteria in the oiled sediment. Throughout the experiment, phylotypes associated with the aerobic degradation of hydrocarbons, including polycyclic aromatic hydrocarbons (PAHs) (Cycloclasticus) and alkanes (Alcanivorax,Oleibacter, andOceanospirillalesstrain ME113), substantively increased in oiled mesocosms, collectively representing 2% of the pyrosequences in the oiled sediments at day 21. Tidal biofilms from oiled cores at day 22, however, consisted mostly of phylotypes related toAlcanivorax borkumensis(49% of clones),Oceanospirillalesstrain ME113 (11% of clones), and diatoms (14% of clones). Thus, aerobic hydrocarbon biodegradation is most likely to be the main mechanism of attenuation of crude oil in the early weeks of an oil spill, with tidal biofilms representing zones of high hydrocarbon-degrading activity.
APA, Harvard, Vancouver, ISO, and other styles
5

YOKOYAMA, T., K. YUYAMA, I. AKOJIMA, and S. MORIYA. "The Rocket Fighter Shusui—as Re-developed from Incomplete and Vague Me163B Data." Transactions of the Newcomen Society 70, no. 1 (January 1998): 257–76. http://dx.doi.org/10.1179/tns.1998.015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Middleton, Douglas. "The profile packThe profile pack Mailing MacDonald et al ME13 8AR FavershamKent£15.95 incl postage." Nursing Standard 6, no. 18 (January 22, 1992): 44. http://dx.doi.org/10.7748/ns.6.18.44.s53.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Slingluff, Jr., Craig L., Gina R. Petroni, Kimberly A. Chianese-Bullock, Nolan A. Wages, Walter C. Olson, Kelly T. Smith, Kathleen Haden, et al. "Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)." Journal for ImmunoTherapy of Cancer 9, no. 1 (January 2021): e000934. http://dx.doi.org/10.1136/jitc-2020-000934.

Full text
Abstract:
BackgroundPeptide vaccines designed to stimulate melanoma-reactive CD4+ T cells can induce T cell and antibody (Ab) responses, associated with enhanced overall survival. We hypothesized that adding toll-like receptor 3 agonist polyICLC to an incomplete Freund’s adjuvant (IFA) would be safe and would support strong, durable CD4+ T cell and Ab responses. We also hypothesized that oral low-dose metronomic cyclophosphamide (mCy) would be safe, would reduce circulating regulatory T cells (T-regs) and would further enhance immunogenicity.Participants and methodsAn adaptive design based on toxicity and durable CD4+ T cell immune response (dRsp) was used to assign participants with resected stage IIA-IV melanoma to one of four study regimens. The regimens included a vaccine comprising six melanoma peptides restricted by Class II MHC (6MHP) in an emulsion with IFA alone (Arm A), with IFA plus systemic mCy (Arm B), with IFA+ local polyICLC (Arm C), or with IFA+ polyICLC+ mCy (Arm D). Toxicities were recorded (CTCAE V.4.03). T cell responses were measured by interferon γ ELIspot assay ex vivo. Serum Ab responses to 6MHP were measured by ELISA. Circulating T-regs were assessed by flow cytometry.ResultsForty-eight eligible participants were enrolled and treated. Early data on safety and dRsp favored enrollment on arm D. Total enrollment on Arms A-D were 3, 7, 6, and 32, respectively. Treatment-related dose-limiting toxicities (DLTs) were observed in 1/7 (14%) participants on arm B and 2/32 (6%) on arm D. None exceeded the 25% DLT threshold for early closure to enrollment for any arm. Strong durable T cell responses to 6MHP were detected ex vivo in 0%, 29%, 67%, and 47% of participants on arms A-D, respectively. IgG Ab responses were greatest for arms C and D. Circulating T-regs frequencies were not altered by mCy.Conclusions6MHP vaccines administered with IFA, polyICLC, and mCy were well tolerated. The dRsp rate for arm D of 47% (90% CI 32 to 63) exceeded the 18% (90% CI 11 to 26) rate previously observed with 6MHP in IFA alone. Vaccination with IFA+ polyICLC (arm C) also showed promise for enhancing T cell and Ab responses.
APA, Harvard, Vancouver, ISO, and other styles
8

Guan, Z., J. Sun, Z. Wang, Y. Geng, and W. Xu. "Development of an Open Metadata Schema for Prospective Clinical Research (openPCR) in China." Methods of Information in Medicine 53, no. 01 (2014): 39–46. http://dx.doi.org/10.3414/me13-01-0008.

Full text
Abstract:
SummaryObjectives: In China, deployment of electronic data capture (EDC) and clinical data management system (CDMS) for clinical research (CR) is in its very early stage, and about 90% of clinical studies collected and submitted clinical data manually. This work aims to build an open metadata schema for Prospective Clinical Research (openPCR) in China based on openEHR archetypes, in order to help Chinese researchers easily create specific data entry templates for registration, study design and clinical data collection.Methods: Singapore Framework for Dublin Core Application Profiles (DCAP) is used to develop openPCR and four steps such as defining the core functional requirements and deducing the core metadata items, developing archetype models, defining metadata terms and creating archetype records, and finally developing implementation syntax are followed.Results: The core functional requirements are divided into three categories: requirements for research registration, requirements for trial design, and requirements for case report form (CRF). 74 metadata items are identified and their Chinese authority names are created. The minimum metadata set of openPCR includes 3 documents, 6 sections, 26 top level data groups, 32 lower data groups and 74 data elements. The top level container in openPCR is composed of public document, internal document and clinical document archetypes. A hierarchical structure of openPCR is established according to Data Structure of Electronic Health Record Architecture and Data Stand -ard of China (Chinese EHR Standard). Meta-data attributes are grouped into six parts: identification, definition, representation, relation, usage guides, and administration.Discussions and Conclusion: OpenPCR is an open metadata schema based on research registration standards, standards of the Clinical Data Interchange Standards Consortium (CDISC) and Chinese healthcare related stand -ards, and is to be publicly available throughout China. It considers future integration of EHR and CR by adopting data structure and data terms in Chinese EHR Standard. Archetypes in openPCR are modularity models and can be separated, recombined, and reused. The authors recommend that the method to develop openPCR can be referenced by other countries when designing metadata schema of clinical research. In the next steps, openPCR should be used in a number of CR projects to test its applicability and to continuously improve its coverage. Besides, metadata schema for research protocol can be developed to structurize and standardize protocol, and syntactical interoperability of openPCR with other related standards can be considered.
APA, Harvard, Vancouver, ISO, and other styles
9

Keller, H., M. Müller-Engelmann, M. Heinzel-Gutenbrunner, T. Krones, N. Donner-Banzhoff, and O. Hirsch. "Trying to Optimise the German Version of the OPTION Scale Regarding the Dyadic Aspect of Shared Decision Making." Methods of Information in Medicine 52, no. 06 (2013): 514–21. http://dx.doi.org/10.3414/me13-01-0011.

Full text
Abstract:
Summary Objectives: The OPTION scale (“observing patient involvement in decision making”) assesses the extent to which clinicians involve patients in decisions across a range of situations in clinical practice. It so far just covers physician behavior. We intended to modify the scoring of the OPTION scale to incorpo -rate active patient behavior in consultations. Methods: Modification was done on scoring level, attempting a dyadic, relationship-centred approach in that high ratings can be evoked also by the behaviour of active patients. The German version of the OPTION scale was compared with a modified version by analysing video recordings of primary care consultations dealing with cardiovascular prevention. Fifteen general practitioners provided 40 videotaped consultations. Videos were analysed by two rater pairs and two experts in shared decision making (SDM). Results: Reliability measures of the modified version were lower than those of the original scale. Significant associations of the dichotomised scale with the expert SDM rating as well as with physicians’ expertise in SDM were only found for the modified OPTION scale. Receiver Operating Characteristic (ROC) analyses confirmed a valid differentiation between the presence of SDM (yes/no) on total score level, even though the cut-off point was quite low. Standard deviations of the single items in the modified version were higher compared to the original OPTION scale, while the means of total scores were similar. Conclusions: The original OPTION scale is physician-centered and neglects the activity and a possible self-involvement of the patient. Our modified instruction was able to capture the dyadic element partially. The development of a separate dyadic instrument might be more promising.
APA, Harvard, Vancouver, ISO, and other styles
10

Luzi, D., and F. Pecoraro. "The Integration of the Risk Management Process with the Lifecycle of Medical Device Software." Methods of Information in Medicine 53, no. 02 (2014): 92–98. http://dx.doi.org/10.3414/me13-01-0014.

Full text
Abstract:
SummaryObjectives: The application of software in the Medical Device (MD) domain has become central to the improvement of diagnoses and treatments. The new European regulations that specifically address software as an important component of MD, require complex procedures to make software compliant with safety requirements, introducing thereby new challenges in the qualification and classi -fication of MD software as well as in the performance of risk management activities. Under this perspective, the aim of this paper is to propose an integrated framework that combines the activities to be carried out by the manufacturer to develop safe software within the development lifecycle based on the regulatory requirements reported in US and European regulations as well as in the relevant standards and guidelines.Methods: A comparative analysis was carried out to identify the main issues related to the application of the current new regulations. In addition, standards and guidelines recently released to harmonise procedures for the validation of MD software have been used to define the risk management ac -tivities to be carried out by the manufacturer during the software development process.Results: This paper highlights the main issues related to the qualification and classification of MD software, providing an analysis of the different regulations applied in Europe and the US. A model that integrates the risk management process within the software development lifecycle has been proposed too. It is based on regulatory requirements and considers software risk analysis as a central input to be managed by the manufacturer already at the initial stages of the software design, in order to prevent MD failures.Conclusions: Relevant changes in the process of MD development have been introduced with the recognition of software being an important component of MDs as stated in regulations and standards. This implies the performance of highly iterative processes that have to integrate the risk management in the framework of software development. It also makes it necessary to involve both medical and software engineering competences to safeguard patient and user safety.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "ME163"

1

Allemant, Castañeda Eric, Collantes Ricardo Alfredo Arones, Dias Luis Fernando Oscar Carlos Arrieta, and Sara-Lafosse Diego Barrenechea. "Terapéutica Integrada - ME163 201901." Universidad Peruana de Ciencias Aplicadas (UPC), 2019. http://hdl.handle.net/10757/627925.

Full text
Abstract:
Curso de especialidad, de la carrera de medicina, de carácter teórico-práctico del ciclo 8,en el que los estudiantes al realizar la revisión y análisis de casos clínicos elaboran los planes de prevención y tratamiento de los principales problemas de salud. El curso de terapéutica integrada busca desarrollar las competencias específicas de práctica clínica-promoción, prevención y tratamiento(nivel 2) y profesionalismo-sentido ético y legal y responsabilidad profesional(nivel 2),que les permitirá a los estudiantes plantear los planes de prevención y tratamiento farmacológico y no farmacológico de los principales problemas de salud en el paciente adulto y pediátrico.
APA, Harvard, Vancouver, ISO, and other styles
2

Aliaga, Viera Segundo Eleazar, Campos Cynthia Lissette Bejarano, De La Cruz Yessenia Vanessa Calderón, and Caceres Gunter Callata. "Farmacología - ME143 201602." Universidad Peruana de Ciencias Aplicadas (UPC), 2016. http://hdl.handle.net/10757/627039.

Full text
Abstract:
El curso específico de la carrera de Medicina, de carácter teórico-práctico dirigido a los estudiantes del 3er ciclo, que busca desarrollar la competencia general Manejo de Información (nivel 1) y la competencia específica de Práctica Clínica - Promoción, Prevención y Tratamiento (nivel 1). El conocimiento de la farmacología general permitirá al estudiante orientar su estudio posterior de los medicamentos aplicados en los distintos sistemas orgánicos del ser humano, considerando sus mecanismos de acción, efectos y su disposición en el organismo a través de los fluidos corporales (Farmacocinética), así como su dinámica tisular (Farmacodinamia). Así mismo, el estudiante deberá considerar los conceptos básicos de los efectos secundarios, las interacciones de los medicamentos con otras sustancias, los factores propios del paciente (fisiología y patología) y de los microrganismos, mismos que podrían afectar el comportamiento de las drogas y por lo tanto la efectividad y pertinencia de la terapia considerada.
APA, Harvard, Vancouver, ISO, and other styles
3

Aliaga, Viera Segundo Eleazar, Sanchez De Vasquez Jovita Nelly Alvarez, Campos Cynthia Lissette Bejarano, and De La Cruz Yessenia Vanessa Calderón. "Farmacología - ME143 201701." Universidad Peruana de Ciencias Aplicadas (UPC), 2017. http://hdl.handle.net/10757/627116.

Full text
Abstract:
El curso específico de la carrera de Medicina, de carácter teórico-práctico dirigido a los estudiantes del 3er ciclo, que busca desarrollar la competencia general Manejo de Información (nivel 1) y la competencia específica de Práctica Clínica - Promoción, Prevención y Tratamiento (nivel 1). El conocimiento de la farmacología general permitirá al estudiante orientar su estudio posterior de los medicamentos aplicados en los distintos sistemas orgánicos del ser humano, considerando sus mecanismos de acción, efectos y su disposición en el organismo a través de los fluidos corporales (Farmacocinética), así como su dinámica tisular (Farmacodinamia). Así mismo, el estudiante deberá considerar los conceptos básicos de los efectos secundarios, las interacciones de los medicamentos con otras sustancias, los factores propios del paciente (fisiología y patología) y de los microrganismos, mismos que podrían afectar el comportamiento de las drogas y por lo tanto la efectividad y pertinencia de la terapia considerada.
APA, Harvard, Vancouver, ISO, and other styles
4

Aliaga, Viera Segundo Eleazar, De La Cruz Yessenia Vanessa Calderón, Alfaro Marilin Paola Maguiña, and Casavilca Michan Alberto Malca. "Farmacología - ME143 201700." Universidad Peruana de Ciencias Aplicadas (UPC), 2017. http://hdl.handle.net/10757/627115.

Full text
Abstract:
El curso específico de la carrera de Medicina, de carácter teórico-práctico dirigido a los estudiantes del 3er ciclo, que busca desarrollar la competencia general Manejo de Información (nivel 1) y la competencia específica de Práctica Clínica - Promoción, Prevención y Tratamiento (nivel 1). El conocimiento de la farmacología general permitirá al estudiante orientar su estudio posterior de los medicamentos aplicados en los distintos sistemas orgánicos del ser humano, considerando sus mecanismos de acción, efectos y su disposición en el organismo a través de los fluidos corporales (Farmacocinética), así como su dinámica tisular (Farmacodinamia). Así mismo, el estudiante deberá considerar los conceptos básicos de los efectos secundarios, las interacciones de los medicamentos con otras sustancias, los factores propios del paciente (fisiología y patología) y de los microrganismos, mismos que podrían afectar el comportamiento de las drogas y por lo tanto la efectividad y pertinencia de la terapia considerada.
APA, Harvard, Vancouver, ISO, and other styles
5

Aguirre, Sosa Ildauro, Fernandez Melba Lourdes Agüero, Calderón Alfredo Lorenzo Aliaga, and Lopez Cesar Francisco Amanzo. "Clínica Integrada - ME162 201802." Universidad Peruana de Ciencias Aplicadas (UPC), 2018. http://hdl.handle.net/10757/626975.

Full text
Abstract:
Curso de especialidad, de la carrera de medicina, de carácter teórico- práctico del ciclo 7, en el que los estudiantes al establecer una buena relación con el paciente y/o familiar realizan la anamnesis, que es una entrevista dirigida al problema de salud que presenta el paciente, realizan el examen físico e integran conocimientos que servirán para establecer el diagnostico por síndromes o problemas y el plan de trabajo. El curso de Clínica integrada busca desarrollar las competencias generales de comunicación escrita y comunicación oral(nivel 2)y las competencias específicas de práctica clínica-diagnóstico (nivel 2) y profesionalismo-sentido ético y legal y responsabilidad profesional(nivel 2.La elaboración de una historia clínica orientada por problemas permitirá al estudiante, plantear un adecuado plan de trabajo y terapéutico para su paciente.
APA, Harvard, Vancouver, ISO, and other styles
6

Aguirre, Sosa Ildauro, Calderón Alfredo Lorenzo Aliaga, Carhuanchot Victor Aliaga, and Castañeda Eric Allemant. "Clínica Integrada - ME162 201901." Universidad Peruana de Ciencias Aplicadas (UPC), 2019. http://hdl.handle.net/10757/626977.

Full text
Abstract:
Curso de especialidad, de la carrera de medicina, de carácter teórico- práctico del ciclo 7, en el que los estudiantes al establecer una buena relación con el paciente y/o familiar realizan la anamnesis, que es una entrevista dirigida al problema de salud que presenta el paciente, realizan el examen físico e integran conocimientos que servirán para establecer el diagnostico por síndromes o problemas y el plan de trabajo. El curso de Clínica integrada busca desarrollar las competencias generales de Comunicación escrita y Comunicación oral(nivel 2) y las competencias específicas de práctica clínica-diagnóstico (nivel 2) y profesionalismo-sentido ético y legal y responsabilidad profesional(nivel 2). La elaboración de una historia clínica orientada por problemas permitirá al estudiante, plantear un adecuado plan de trabajo y terapéutico para su paciente.
APA, Harvard, Vancouver, ISO, and other styles
7

Balarezo, López Gunther Naldo, Hinostroza Geimy Magaly Camargo, Retamozo Julia Concepcion Carrasco, and Davila Miguel Davila. "Diagnóstico Comunitario - ME168 201901." Universidad Peruana de Ciencias Aplicadas (UPC), 2019. http://hdl.handle.net/10757/626983.

Full text
Abstract:
Mejorar las condiciones de salud de las comunidades constituye el objetivo principal de la salud pública y para lograrlo se requiere, antes que nada, conocer el estado de salud de sus habitantes, así como los determinantes sociales que luego configuran sus desigualdades sanitarias. El estado de salud de una población usualmente se determina en las instituciones de salud con base a la información obtenida en los establecimientos de salud que la atienden y de fuentes primarias como censos, encuestas y estudios especiales. Si bien estas fuentes son válidas, un buen diagnóstico debe involucrar a los actores sociales de base en la comunidad para que luego se comprometan en adoptar estrategias y actividades que mejoren sus condiciones de salud. Diagnóstico Comunitario es un curso de especialidad en la carrera de medicina de carácter teórico-práctico que busca ofrecer las herramientas básicas para que un egresado pueda generar evidencia y analizar la situación de salud de una población, en conjunto con los actores sociales de base. El curso busca desarrollar la competencia general de ciudadanía Nivel 3 y la competencia específica de Práctica de Salud Pública: Diagnóstico Situacional, Nivel 2, en las siguientes dimensiones: Salud Internacional y Global: Describe las dimensiones globales de las acciones locales en salud, las implicaciones locales de los eventos globales y contrasta diferentes sistemas de prestación de servicios y sus implicaciones en los usuarios; Análisis de Situación de Salud: Construye evidencia sobre la situación de salud de la población, las desigualdades en riesgos, resultados y acceso a servicios de salud, y desarrolla buenas prácticas de análisis de la información sobre salud.
APA, Harvard, Vancouver, ISO, and other styles
8

Ampuero, Caceres Rosa Violeta, Collantes Ricardo Alfredo Arones, Soldi Jose Antonio Martin Arrus, and Velásquez Jack Juan Ávila. "Seminario Integrador - ME103 201402." Universidad Peruana de Ciencias Aplicadas (UPC), 2014. http://hdl.handle.net/10757/626990.

Full text
Abstract:
Seminario Integrador es el curso que tiene por objetivo lograr que el alumno adquiera, a través de la revisión de temas y análisis de casos y preguntas de todos los capítulos del área médica, una adecuada integración de sus conocimientos, además de un óptimo nivel de habilidades y destrezas para la resolución del examen nacional de medicina (ENAM), con lo cual podrá establecer diagnósticos correctos de los problemas médicos en su práctica hospitalaria así como obtener un resultado satisfactorio en la evaluación del ENAM.
APA, Harvard, Vancouver, ISO, and other styles
9

Amanzo, Lopez Cesar Francisco, Collantes Ricardo Alfredo Arones, Alegre Juan Carlos Arrasco, and Soldi Jose Antonio Martin Arrus. "Seminario Integrador - ME103 201802." Universidad Peruana de Ciencias Aplicadas (UPC), 2018. http://hdl.handle.net/10757/627366.

Full text
Abstract:
Curso de la especialidad,de la carrera de medicina,de carácter práctico del ciclo 12,en el que los estudiantes al realizar la revisión y análisis de casos clínicos de todas las especialidades médicas y de salud pública elaboran diagnósticos,planes de trabajo y terapéutico. El curso de seminario integrador busca desarrollar las competencias generales de: pensamiento crítico y ciudadanía (nivel 3) y las competencias específicas de práctica clínica-promoción, prevención y tratamiento(nivel 3), práctica de salud pública-diagnóstico situacional e intervención de salud pública(nivel 3) y profesionalismo- aprendizaje autónomo y desarrollo profesional(nivel 3). El curso de seminario integrador les permitirá a los estudiantes tomar decisiones ante los diferentes retos diagnósticos del paciente y de la comunidad como miembro de un equipo interprofesional en su futura vida profesional.
APA, Harvard, Vancouver, ISO, and other styles
10

Aliaga, Viera Segundo Eleazar, Lopez Cesar Francisco Amanzo, Collantes Ricardo Alfredo Arones, and Soldi Jose Antonio Martin Arrus. "Seminario Integrador - ME103 201502." Universidad Peruana de Ciencias Aplicadas (UPC), 2015. http://hdl.handle.net/10757/626988.

Full text
Abstract:
Seminario Integrador es el curso de especialidad de la carrera de Medicina, de carácter teórico-práctico dirigido a los estudiantes del ciclo doce, que busca desarrollar la competencia general de Aprendizaje Autónomo y Pensamiento Crítico. Tiene por objetivo lograr que el alumno adquiera, a través de la revisión de temas, preguntas y análisis de casos clínicos de todos los capítulos del área médica, una adecuada integración de sus conocimientos, con lo cual podrá establecer diagnósticos correctos de los problemas médicos en su práctica hospitalaria, y además obtener un óptimo nivel de habilidades y destrezas en la resolución de exámenes de selección hospitalarias para realizar el externado médico, así como un resultado satisfactorio en la evaluación del Examen Nacional de Medicina (ENAM).
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "ME163"

1

The Miocene Ocean: Paleoceanography and Biogeography. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "ME163"

1

Sclater, John G., Linda Meinke, Andrew Bennett, and Cynthia Murphy. "The depth of the ocean through the Neogene." In Geological Society of America Memoirs, 1–20. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Vincent, Edith, John S. Killingley, and Wolfgang H. Berger. "Miocene oxygen and carbon isotope stratigraphy of the tropical Indian Ocean." In Geological Society of America Memoirs, 103–30. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Keller, Gerta. "Depth stratification of planktonic foraminifers in the Miocene ocean." In Geological Society of America Memoirs, 177–96. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p177.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kennett, James P., Gerta Keller, and M. S. Srinivasan. "Miocene planktonic foraminiferal biogeography and paleoceanographic development of the Indo-Pacific region." In Geological Society of America Memoirs, 197–236. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p197.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Barron, John A., Gerta Keller, and Dean A. Dunn. "A multiple microfossil biochronology for the Miocene." In Geological Society of America Memoirs, 21–36. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Romine, Karen. "Radiolarian biogeography and paleoceanography of the North Pacific at 8 Ma." In Geological Society of America Memoirs, 237–72. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Romine, Karen, and Gail Lombari. "Evolution of Pacific circulation in the Miocene: Radiolarian evidence from DSDP Site 289." In Geological Society of America Memoirs, 273–90. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p273.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lombari, Gail. "Biogeographic trends in Neogene radiolaria from the Northern and Central Pacific." In Geological Society of America Memoirs, 291–304. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p291.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Stein, Ruediger. "The post-Eocene sediment record of DSDP Site 366: Implications for African climate and plate tectonic drift." In Geological Society of America Memoirs, 305–16. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p305.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Burckle, Lloyd H., and Neil D. Opdyke. "Latest Miocene/earliest Pliocene diatom correlations in the North Pacific." In Geological Society of America Memoirs, 37–48. Geological Society of America, 1985. http://dx.doi.org/10.1130/mem163-p37.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "ME163"

1

Pashaie, Ramin, and Nabil Farhat. "Equilibrium-State Emission of Electron-Trapping Material Thin-Film for applications in Nonlinear-Dynamics." In International Optical Design Conference. Washington, D.C.: OSA, 2006. http://dx.doi.org/10.1364/iodc.2006.me13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sharma, Pratibha, and Harry Kwok. "Design and Implementation of Organic LED-Based Displays for Signage Application." In International Optical Design Conference. Washington, D.C.: OSA, 2006. http://dx.doi.org/10.1364/iodc.2006.me16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lakó, Sándor. "Bessel-Gauss beam optical resonator with radially polarized output." In Optical Amplifiers and Their Applications. Washington, D.C.: OSA, 2005. http://dx.doi.org/10.1364/oaa.2005.me13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Crognale, C., and S. Caputo. "All-Optical De-Multiplexer based on Cross Gain Modulation in Semiconductor Optical Amplifiers." In Optical Amplifiers and Their Applications. Washington, D.C.: OSA, 2005. http://dx.doi.org/10.1364/oaa.2005.me16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Biggs, Jason D., and Jeffrey A. Cina. "Monitoring the External Vibrational Control of Excitation-Energy Transfer Using Pump-Probe Polarization Spectroscopy." In International Conference on Ultrafast Phenomena. Washington, D.C.: OSA, 2010. http://dx.doi.org/10.1364/up.2010.me13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Heisler, Ismael A., and Stephen R. Meech. "Ultrafast Polarized Raman as a Probe of Solvation Shell Structure and Dynamics in Aqueous Salt Solutions." In International Conference on Ultrafast Phenomena. Washington, D.C.: OSA, 2010. http://dx.doi.org/10.1364/up.2010.me16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Itakura, Ryuji, Jun Watanabe, Taiki Asano, and Kaoru Yamanouchi. "Reaction dynamics of hydrogen bonded aniline-ammonia clusters in intense laser fields by tandem mass spectroscopy." In International Conference on Ultrafast Phenomena. Washington, D.C.: OSA, 2002. http://dx.doi.org/10.1364/up.2002.me13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

An, Q., W. Zinth, and P. Gilch. "Femtosecond Fluorescence Lifetimes Determined by an Intrinsic Raman Gate." In International Conference on Ultrafast Phenomena. Washington, D.C.: OSA, 2002. http://dx.doi.org/10.1364/up.2002.me16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Izumida, Shinji, Zhenlin Liu, Shingo Ono, Hideyuki Ohtake, and Nobuhiko Sarukura. "Spectrum control of coherent, short-pulse, far-infrared radiation from InAs under magnetic field irradiated with stretched femtosecond laser pulses." In Advanced Solid State Lasers. Washington, D.C.: OSA, 2001. http://dx.doi.org/10.1364/assl.1999.me13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kleine, Klaus R. F., Leonel P. Gonzalez, Rajan Bhatia, Larry R. Marshall, and David G. Matthews. "High Brightness Nd:YVO4 Laser for Nonlinear Optics." In Advanced Solid State Lasers. Washington, D.C.: OSA, 2001. http://dx.doi.org/10.1364/assl.1999.me16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'ME163' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography